Serum thrombopoietin level in various hematological diseases

Stem Cells

Volumn 14, Issue 5, 1996, Pages 558-565

  Usuki, Kensuke ^a   Tahara, Tomoyuki ^b   Iki, Seiko ^a   Endo, Mitsue ^a   Osawa, Mayumi ^a   Kitazume, Koichi ^a   Kato, Takashi ^b   Miyazaki, Hiroshi ^b   Urabe, Akio ^a  

^a Kanto Teishin Hospital   (Japan)

^b KIRIN BREWERY CO LTD   (Japan)

Author keywords

Aplastic anemia; Idiopathic thrombocytopenic purpura; Leukemia; Liver cirrhosis; Malignant lymphoma; Multiple myeloma; Myelodysplastic syndrome; Myeloproliferative disorders; Myelosuppressive state; Serum level; Thrombopoietin

Indexed keywords

THROMBOPOIETIN;

APLASTIC ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HEMATOLOGIC DISEASE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LEUKEMIA; LIVER CIRRHOSIS; LYMPHOMA; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; THROMBOCYTE COUNT; THROMBOCYTOPOIESIS;

PURPURA;

EID: 0029744304     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.140558     Document Type: Article

References (40)

1. Gordon MS, Hoffman R. Growth factors affecting human thrombopoiesis: potential agents for the treatment of thrombocytopenia. Blood 1992;80:302-307.
2. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 1995;86:419-431.
3. Quesenberry PJ, Ihle JN, McGrath E. The effect of interleukin 3 and GM-CSA-2 on megakaryocyte and myeloid clonal colony formation. Blood 1985;65:214-217.
4. Ganser A, Lindermann A, Seipelt G et al. Effect of recombinant human interleukin-3 in aplastic anemia. Blood 1990;76:1287-1292.
5. Dessyrpris EN, Gleaton JH, Armstrong OL. Effect of human recombinant erythropoietin on human marrow megakaryocyte colony formation in vitro. Br J Haematol 1987;65:265-269.
6. Berridge MV, Fraser JK, Carter JM et al. Effect of recombinant human erythropoietin on megakaryocytes and on platelet production in the rat. Blood 1988;72:970-977.
7. Urabe A, Takaku F, Mizoguchi H et al. Effect of recombinant erythropoietin on the anemia of chronic renal failure. Int J Cell Cloning 1988;6:179-191.
8. Ikebuchi K, Wong GG, Clark SC et al. Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 1987;84:9035-9039.
9. D'Hondt, Humblet Y, Guillaume Th et al. Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo-controlled, randomized Phase Ib study. Blood 1995;85:2347-2353.
10. Du XX, Williams DA. Interleukin-11: a multifunctional growth factor derived from the hematopoietic microenvironment. Blood 1994;83:2023-2030.
11. Paul SR, Bennet F, Calveti JA et al. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci USA 1990;87:7512-7516.
12. Neeben TY, Loebelenz J, Hayes L et al. Recombinant human interleukin-11 stimulates megakaryocytopoiesis and increases peripheral platelets in normal and splenectomized mice. Blood 1993;81:901-908.
13. Kato T, Ogami K, Shimada Y et al. Purification and characterization of thrombopoietin. J Biochem 1995;118:229-236.
14. Ogami K, Shimada Y, Sohma Y et al. The sequence of a rat cDNA encoding thrombopoietin. Gene 1995;158:309-310.
15. Sohma Y, Akahori H, Seki N et al. Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Lett 1994;353:57-61.
16. de Sauvage FJ, Hass PE, Spencer SD et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-mpl ligand. Nature 1994;369:533-538.
17. Lok S, Kaushansky K, Holly RD et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994;369:565-568.
18. Bartley TD, Bogenberger J, Hunt P et al. Identification and cloning of megakaryocyte growth and development factor that is a ligand for the cytokine receptor mpl. Cell 1994;77:1117-1124.
19. Foster DC, Sprecher CA, Grant FJ et al. Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization. Proc Natl Acad Sci USA 1994;91:13023-13027.
20. Kaushansky K, Lok S, Holly RD et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-mpl ligand thrombopoietin. Nature 1994;369:568-571.
21. Broudy V, Lin N, Kaushansky K. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 1995;85:1719-1726.
22. Zeigler FC, de Sauvage F, Widmer R et al. In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood 1994;84:4045-4052.
23. Wendling F, Maraskovsky E, Debili N et al. c-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 1994;369:571-574.
24. Miyazaki H, Horie K, Tahara T et al. Biological properties of thrombopoietin (TPO). Blood 1994;84(suppl 1):242a.
25. Hunt P. The physiologic role and therapeutic potential of the mpl-ligand in thrombopoiesis. STEM CELLS 1995;13:579-587.
26. Kuter DJ, Rosenberg RD. The reciprocal relationship of thrombopoietin (c-mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 1995;85:2720-2730.
27. Tahara T, Usuki K, Sato H et al. A sensitive sandwich ELISA for measuring thrombopoietin in human serum. Br J Haematol 1996;93:783-788.
28. Murphy S, Iland H, Rosenthal D et al. Essential thrombocythemia: an interim report from the polycythemia vera study group. Semin Hematol 1986;23:177-182.
29. Bennet JM, Catovsky D, Daniel MT et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985;103:620-625.
30. Bennet JM, Catovsky D, Daniel MT et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189-199.
31. Bennet JM, Catovsky D, Daniel M-T et al. Criteria for the acute leukemia of megakaryocyte lineage (M7). Ann Intern Med 1985;103:460-462.
32. Bennet JM, Catovsky D, Daniel M-T et al. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0). Ann Intern Med 1991;78:325-329.
33. Bithell TC. Thrombocytopenia. In: Lee GR, Bithell TC, Foerster J et al., eds. Wintrobe's Clinical Hematology. Philadelphia: Lea & Febiger, 1993;2:1325-1328.
34. Debili N, Wendung F, Cosman D et al. The mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood 1995;85:391-401.
35. Kuter DJ, Beeler DL, Rosenberg RD. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci USA 1994;91:11104-11108.
36. Vigon I, Dreyfus F, Melle J et al. Expression of c-mpl proto-oncogene in human hematologic malignancies. Blood 1993;82:877-883.
37. Matsumura I, Kanakura Y, Kato T et al. Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin. Blood 1995;86:703-709.
38. Athens JW. Polycythemia vera. In: Lee GR, Bithell TC, Foerster J et al., eds. Wintrobe's Clinical Hematology. Philadelphia: Lea & Febiger, 1993;2:1999-2017.
39. Shimada Y, Kato T, Ogami K et al. Production of thrombopoietin (TPO) by rat hepatocytes and hepatoma cell lines. Exp Hematol (in press).
40. Urabe A, Saito T, Fukamachi H et al. Serum erythropoietin titers in the anemia of chronic renal failure and other hematological states. Int J Cell Cloning 1987;5:202-208.